Details for Patent: 9,956,231
✉ Email this page to a colleague
Which drugs does patent 9,956,231 protect, and when does it expire?
Patent 9,956,231 protects IMPOYZ and is included in one NDA.
This patent has seven patent family members in five countries.
Summary for Patent: 9,956,231
| Title: | Topical formulations comprising a steroid |
| Abstract: | The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and other associated skin diseases or disorders. |
| Inventor(s): | Ubaidulla; Udhumansha (Namakkal, IN), Kandavilli; Sateesh (Plainsboro, NJ), Vairale; Ajay Sunil (Hyderabad, IN), Wayne; Jeffrey A. (Markham, CA), Nalamothu; Vijendra (Basking Ridge, NJ), Meghal; Mistry (Ahmedabad, IN), Pakunlu; Refika Isil (Highland Park, NJ) |
| Assignee: | DR. REDDY'S LABORATORIES LTD. (Hyderabad, Telangana, IN) |
| Application Number: | 15/843,590 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,956,231 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,956,231
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF MODERATE PLAQUE PSORIASIS | ⤷ Sign Up | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER | ⤷ Sign Up | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | PSORIASIS | ⤷ Sign Up | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS. | ⤷ Sign Up | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF PLAQUE PSORIASIS | ⤷ Sign Up | |||
| Primus Pharms | IMPOYZ | clobetasol propionate | CREAM;TOPICAL | 209483-001 | Nov 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | PLAQUE PSORIASIS | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,956,231
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Denmark | 2473161 | ⤷ Sign Up | |||
| European Patent Office | 2473161 | ⤷ Sign Up | |||
| European Patent Office | 3141246 | ⤷ Sign Up | |||
| Spain | 2637447 | ⤷ Sign Up | |||
| Japan | 2013503203 | ⤷ Sign Up | |||
| Japan | 5833007 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2011026076 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
